Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Persistent Low Rates of Treatment of Metabolic Risk Factors in People With Psychotic Disorders: A PHAMOUS Study PDF $40.00
$40.00
× Placeholder Lack of Generalizability of PTSD Treatment Trials: The Recent Brexpiprazole-Sertraline Trials as an Example PDF $40.00
$40.00
× Placeholder Adherence Assessments and the Use of Depot Antipsychotics in Patients With Schizophrenia. PDF $40.00
$40.00
× Placeholder Relationship Between Costs and Symptoms in Schizophrenia Patients Treated With Antipsychotic Medication: A Review PDF $40.00
$40.00
× Placeholder The Pharmacologic Treatment of Bipolar DisorderEffective Agents in Treating Bipolar Depression PDF $40.00
$40.00
× Placeholder Does Randomized Evidence Support Sertraline as First-Line Antidepressant for Adults With Acute Major Depression? A Systematic Review and Meta-Analysis PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $240.00
Total $240.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe